Windom Allergy, Asthma, Sinus

For all of our patients who have the EpiPen: FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration EpiPen 0.3 mg and EpiPen Jr 0.15 mg auto-injectors, and the authorized generic versions, may potentially have delayed injection or be prevented from properly injecting due to: Device failure from spontaneous activation caused by using sideways force to remove the blue safety release.Device failure from inadvertent or spontaneous activation due to a raised blue safety release.Difficulty removing the device from the carrier tube. For more information: FDA alerts patients and health care professionals of EpiPen...

Our fearless leader, Dr, Hugh Windom, and the newest addition to the Windom Allergy, Dr. Tara Saco, both gave lectures at the annual Univeristy of South Florida Symposium Update in Allergy and Immunology on January 17 & 18. Primary care physicians, surgeons, dermatologists, ear nose and throat specialists, as well as fellow allergists who attended this conference came from all over Florida and some from other states to learn about foor oral immunotherapy (OIT) and mast cell diseases (mastocytosis and mast cell activation syndrome) from Dr. Windom and Dr. Saco, respectively. Windom Allergy continues to be at the forefront of cutting edge Allergy...

The peanut pill, Palforzia, has been approved by the FDA, so what are food allergy patients supposed to think? Here is what we know. Palforzia (peanut flour in a capsule) is to be used as oral immunotherapy (OIT) for 4 to 17 year-olds with a confirmed diagnosis of peanut allergy. It should help mitigate allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts. Those who take Palforzia must continue to avoid peanuts in their diets. The goal is to be slowly desensitized to 300 mg of peanut protein, or approximately one peanut, with the help of an allergist. Studies...